Abstract
Previous studies have shown that systemic up-regulation of erythropoietin (Epo) protects retina from light-induced retinal degeneration. Aranesp (darbepoetin alfa) and AMG114, hyperglycosylated forms of Epo, are recently developed Epo-analogs with an extended circulating half-life in vivo. We tested the protective effect of intravitreal injection of Epo glycosylation analogs in a rat model of retinal degeneration. Albino rats were injected in one eye with 0.2, 2, 20 ng of Aranesp or AMG114, and in the other eye with carrier, and then exposed to bright light (2,700 lx for 6 h) 2 days after the injection. Seven days after the light exposure, electroretinograms (ERG) were recorded and eyes were removed to measure outer nuclear layer (ONL) thickness. The retinal protection due to local injury and systemic anesthesia related to the intravitreal injection procedure was observed at day 1, but was significantly decreased by day 2. The ERG b-wave amplitudes and ONL thickness were not significantly different between right and left eyes in any of experimental groups, indicating no retinal protection by the Epo-analogs functionally and structurally. Aranesp and AM114 delivered intravitreally do not protect rod photoreceptor cells from light-induced damage.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arcasoy MO (2008) The non-haematopoietic biological effects of erythropoietin. Br J Haematol 141:14–31
Faktorovich EG, Steinberg RH, Yasumura D et al (1992) Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat. J Neurosci 12:3554–3567
Grimm C, Wenzel A, Groszer M et al (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8:718–724
Grimm C, Wenzel A, Stanescu D et al (2004) Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24:5651–5658
Noell WK, Walker VS, Kang BS et al (1966) Retinal damage by light in rats. Invest Ophthalmol 5:450–473
Ranchon Cole I, Bonhomme B, Doly M (2007) Pre-treatment of adult rats with high doses of erythropoietin induces caspase-9 but prevents light-induced retinal injury. Exp Eye Res 85:782–789
Rex TS, Allocca M, Domenici L et al (2004) Systemic but not intraocular Epo gene transfer Âprotects the retina from light-and genetic-induced degeneration. Mol Ther 10:855–861
Sinclair AM, Coxon A, McCaffery I et al (2010) Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Blood 115:4264–4272
Swift S, Ellison AR, Kassner P et al (2010) Absence of functional EpoR expression in human tumor cell lines. Blood 115:4254–4263
Tanito M, Kaidzu S, Ohira A et al (2008) Topography of retinal damage in light-exposed albino rats. Exp Eye Res 87:292–295
Tanito M, Li F, Elliott MH et al (2007) Protective effect of TEMPOL derivatives against light-induced retinal damage in rats. Invest Ophthalmol Vis Sci 48:1900–1905
Wen R, Song Y, Cheng T et al (1995) Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina. J Neurosci 15:7377–7385
Wenzel A, Grimm C, Samardzija M et al (2005) Molecular mechanisms of light-induced Âphotoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res 24:275–306
Acknowledgments
The authors are grateful to Mark Dittmar (Dean A. McGee Eye Institute) for maintaining the animals used in this study and to Louisa J. Williams and Linda S. Boone (Dean A. McGee Eye Institute) for their excellent retinal section preparation. This study was supported by a contract from Amgen, Inc. (Thousand Oaks, CA) and grants from the National Eye Institute (EY04149, EY00871, and EY12190); National Center for Research Resources (RR17703); Research to Prevent Blindness, Inc.; and the Foundation Fighting Blindness.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this paper
Cite this paper
Tanito, M., Li, F., Anderson, R.E. (2012). Intravitreal Injection of Erythropoietin Glycosylation Analogs Does Not Protect Rod Photoreceptor Cells from Light-Induced Damage. In: LaVail, M., Ash, J., Anderson, R., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 723. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0631-0_19
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0631-0_19
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0630-3
Online ISBN: 978-1-4614-0631-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)